RedHill Biopharma Ltd (RDHL): RedHill Biopharma Releases Data on Opaga...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	145
Posts	27561
Boards Moderated	3
Alias Born	02/07/2004

midastouch017

Re: None

Wednesday, 09/01/2021 2:34:42 PM

Wednesday, September 01, 2021 2:34:42 PM

RedHill Biopharma Releases Data on Opaganib:

https://finance.yahoo.com/news/biotech-stock-roundup-regn-gives-144402274.html

RedHill Biopharma RDHL announced positive preliminary results from a new preclinical study on opaganib. The candidate was studied in a 3D tissue model of human bronchial epithelial cells to evaluate the in vitro efficacy of opaganib in inhibiting the Delta variant. Opaganib demonstrated strong inhibition of COVID-19 Delta variant in a human bronchial epithelial cells model, adding to prior data demonstrating potent inhibition of all COVID-19 variants tested to date. The global 475-patient phase II/III study with opaganib oral pill in hospitalized COVID-19 patients has completed treatment and follow up phase, with top-line results expected shortly.
-----------------------------------------------------------------

10.25+0.15 (+1.49%)
As of 2:31PM EDT. Market open.
Volume 1,746,709
Avg. Volume 507,150

With 1 hour 30 minutes to go, volume
sure has gone up substantially. (and
as of yet with no news)